GMGeraldine G. Miller

Geraldine G. Miller

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Geraldine G. Miller has a total of 15 co-authors. Here are the top co-authors by number of shared publications:

  • Davis C. Drinkwater

    From the Departments of Medicine (G.G.M., S.F.D., D.B.C., P.P., X.-M.Z.), Pathology (J.B.A.), and Surgery (V.S.R., D.C.D., R.N.P.), Vanderbilt University Medical School, Nashville, Tenn. Dr Zhao is now at the Division of Cardiology, Brigham and Women’s Hospital, Boston, Mass

    1 shared publication
  • Dawn M Kilkenny

    Department of Medicine, Vanderbilt University Medical School Nashville USA

    1 shared publication
  • Donald B. Chomsky

    From the Departments of Medicine (G.G.M., S.F.D., D.B.C., P.P., X.-M.Z.), Pathology (J.B.A.), and Surgery (V.S.R., D.C.D., R.N.P.), Vanderbilt University Medical School, Nashville, Tenn. Dr Zhao is now at the Division of Cardiology, Brigham and Women’s Hospital, Boston, Mass

    1 shared publication
  • James B. Atkinson

    From the Departments of Medicine (G.G.M., S.F.D., D.B.C., P.P., X.-M.Z.), Pathology (J.B.A.), and Surgery (V.S.R., D.C.D., R.N.P.), Vanderbilt University Medical School, Nashville, Tenn. Dr Zhao is now at the Division of Cardiology, Brigham and Women’s Hospital, Boston, Mass

    1 shared publication
  • James W Thomas

    Department of Medicine, Vanderbilt University Medical School Nashville USA

    1 shared publication
  • Jonathan V. Rocheleau

    University of Toronto

    1 shared publication

Latest Publications

  • Fibroblast growth factor receptor‐1 interacts with the T‐cell receptor signalling pathway

    by Victor M Byrd, Dawn M Kilkenny, Michael M Dikov, Martha B Reich, Jonathan V Rocheleau, Wade J Armistead, James W Thomas, Geraldine G Miller

    Fibroblast growth factor receptors are expressed by some T cells, and provide costimulation for these cells. Such receptors allow T cells to respond to fibroblast growth factors expressed in response to injury and inflammation and may provide a mechanism for ‘context‐dependent’ responses to antigens within the local microenvironment. The mechanisms by which fibroblast growth factor receptors might interact with the TCR signalling pathway are not defined. Here we show that the TCR and fibroblast growth factor receptors co‐localize during combined stimulation. Signalling via fibroblast growth factor receptors alone results in phosphorylation of Lck and induces nuclear translocation of nuclear factors of activated T cells. Combined stimulation via fibroblast growth factor receptors and the TCR synergistically enhances the activation of nuclear factors of activated T cells. The results suggest that peptide growth factors produced at sites of injury and inflammation can contribute to the outcome of T‐cell encounters with antigen.


  • Open Access

    Longitudinal Analysis of Fibroblast Growth Factor Expression After Transplantation and Association With Severity of Cardiac Allograft Vasculopathy

    by Geraldine G. Miller, Stacy F. Davis, James B. Atkinson, Donald B. Chomsky, Pedro Pedroso, V. Seenu Reddy, Davis C. Drinkwater, Xiao-Ming Zhao, Richard N. Pierson

    Background —Vascular smooth muscle cell growth factors are postulated to contribute to cardiac allograft vasculopathy (CAV). Few data quantitatively address the timing, location, or stimuli for growth factor expression and relationship to CAV. Methods and Results —Acidic fibroblast growth factor (aFGF) mRNA expression was determined in serial endomyocardial biopsies during the first year after transplantation. Patients with high levels of aFGF mRNA and elevations after the early posttransplant period had significantly more severe CAV than patients with low aFGF and no late elevations. Conclusions —Parenchymal aFGF expression varies between patients and in the same patient over time and correlates with development of CAV.